337 related articles for article (PubMed ID: 32033121)
1. Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia.
Del Gaudio I; Sasset L; Lorenzo AD; Wadsack C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033121
[TBL] [Abstract][Full Text] [Related]
2. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
3. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
4. Circulating cord blood HDL-S1P complex preserves the integrity of the feto-placental vasculature.
Del Gaudio I; Sreckovic I; Zardoya-Laguardia P; Bernhart E; Christoffersen C; Frank S; Marsche G; Illanes SE; Wadsack C
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158632. PubMed ID: 31954174
[TBL] [Abstract][Full Text] [Related]
5. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
[TBL] [Abstract][Full Text] [Related]
6. Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice.
Li F; Xu R; Lin CL; Low BE; Cai L; Li S; Ji P; Huang L; Wiles MV; Hannun YA; Obeid LM; Chen Y; Mao C
FASEB J; 2020 Nov; 34(11):15252-15268. PubMed ID: 32959379
[TBL] [Abstract][Full Text] [Related]
7. Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 Axis.
Del Gaudio I; Hendrix S; Christoffersen C; Wadsack C
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991780
[TBL] [Abstract][Full Text] [Related]
8. Physiological and pathological functions of sphingolipids in pregnancy.
Fakhr Y; Brindley DN; Hemmings DG
Cell Signal; 2021 Sep; 85():110041. PubMed ID: 33991614
[TBL] [Abstract][Full Text] [Related]
9. The feto-placental endothelium in pregnancy pathologies.
Wadsack C; Desoye G; Hiden U
Wien Med Wochenschr; 2012 May; 162(9-10):220-4. PubMed ID: 22717877
[TBL] [Abstract][Full Text] [Related]
10. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid Metabolism and Signaling in Endothelial Cell Functions.
Sasset L; Di Lorenzo A
Adv Exp Med Biol; 2022; 1372():87-117. PubMed ID: 35503177
[TBL] [Abstract][Full Text] [Related]
14. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.
Brownbill P; Mills TA; Soydemir DF; Sibley CP
Placenta; 2008 Nov; 29(11):950-5. PubMed ID: 18845336
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-l in feto-placental tissues from normotensive pregnant women and women with pre-eclampsia.
Singh HJ; Rahman A; Larmie ET; Nila A
Acta Obstet Gynecol Scand; 2001 Feb; 80(2):99-103. PubMed ID: 11167202
[TBL] [Abstract][Full Text] [Related]
16. Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas.
Benoit C; Zavecz J; Wang Y
Placenta; 2007; 28(5-6):498-504. PubMed ID: 17070574
[TBL] [Abstract][Full Text] [Related]
17. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
Suh JH; Degagné É; Gleghorn EE; Setty M; Rodriguez A; Park KT; Verstraete SG; Heyman MB; Patel AS; Irek M; Gildengorin GL; Hubbard NE; Borowsky AD; Saba JD
Inflamm Bowel Dis; 2018 May; 24(6):1321-1334. PubMed ID: 29788359
[TBL] [Abstract][Full Text] [Related]
19. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
20. The role of sphingolipids in endothelial barrier function.
Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA
Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
